Abbott Laboratories vs Accelus
Side-by-side comparison of AI visibility scores, market position, and capabilities
Diversified healthcare company with $20-22B revenue; FreeStyle Libre CGM, cardiovascular devices, and diagnostics across medical devices, nutrition, and pharma.
About
Abbott Laboratories is a diversified global healthcare company operating across diagnostics, medical devices, nutritional products, and established pharmaceuticals in over 160 countries. Founded in 1888 by Dr. Wallace Calvin Abbott in Chicago, Illinois and listed on the NYSE, Abbott generates approximately $20-22 billion in annual revenue and employs over 100,000 people globally. The company's portfolio spans four major segments: Medical Devices, Diagnostics, Nutrition, and Established Pharmaceuticals.
Accelus is a global leader in expandable interbody spinal implant technology with 32,000+ cages implanted in 25 countries; secured new equity financing in May 2025 led by Concord Health Partners;
About
Accelus is a medical device company specializing in expandable interbody spinal implant technology. Its products include bi-directional expandable cages designed to address height, lordosis, and weight parameters during spinal fusion surgery, providing the structural stability of monolithic implants while enabling minimally invasive delivery. With more than 32,000 cages implanted across 25 countries, Accelus has established a strong international commercial presence in the spine surgery market.
Key Details
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.